Background Chronic posttraumatic stress disorder (PTSD) is a disabling condition that generates
considerable morbidity, mortality, and both medical and indirect social costs. Treatment …

We report follow-up data evaluating the long-term outcomes for the first completed trial of 3,4-methylenedioxymethamphetamine
(MDMA)-assisted psychotherapy for chronic, treatment-…

Unsuccessfully treated posttraumatic stress disorder (PTSD) is a serious and life-threatening
disorder. Two medications, paroxetine hydrochloride and sertraline hydrochloride, are …

A double-blind, randomized, active placebo-controlled pilot study was conducted to examine
safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 …

Importance There is a pressing need for development of novel pharmacology for the
treatment of Posttraumatic Stress Disorder (PTSD). Given increasing use of medical cannabis …

Post-traumatic stress disorder (PTSD) presents a major public health problem for which
currently available treatments are modestly effective. We report the findings of a randomized, …

Background Post-traumatic stress disorder (PTSD) is prevalent in military personnel and
first responders, many of whom do not respond to currently available treatments. This study …

This multi-site, randomized, double-blind, confirmatory phase 3 study evaluated the efficacy
and safety of 3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) versus …

Background Posttraumatic stress disorder is a prevalent mental health condition with substantial
impact on daily functioning that lacks sufficient treatment options. Here we evaluate six …

Rationale Posttraumatic stress disorder (PTSD) is a chronic condition that has wide-ranging
negative effects on an individual’s health and interpersonal relationships. Treatments with …